key: cord-0860746-c02xzjao authors: Duarte, N.; Arora, R.; Bennett, G.; Wang, M.; Snyder, M. P.; Cooperstock, J. R.; Wagner, C. E. title: Deploying wearable sensors for pandemic mitigation date: 2022-02-08 journal: nan DOI: 10.1101/2022.02.07.22270634 sha: 46adcf52eb65257ebdd33d6cda2253692f4d283c doc_id: 860746 cord_uid: c02xzjao Wearable sensors can continuously and passively detect potential respiratory infections, before or absent symptoms. However, the population-level impact of deploying these devices during pandemics is unclear. We built a compartmental model of Canada's second COVID-19 wave and simulated wearable sensor deployment scenarios, systematically varying detection algorithm accuracy, uptake, and adherence. With current detection algorithms and 4% uptake, we found that deploying wearable sensors could have averted 9% of second wave SARS-CoV-2 infections, though 29% of this reduction is attributed to incorrectly quarantining uninfected device users. Improving detection specificity and offering confirmatory rapid tests each minimized incorrect quarantines and associated costs. With a sufficiently low false positive rate, increasing uptake and adherence became effective strategies for scaling averted infections. We concluded that wearable sensor deployment can meaningfully contribute to pandemic mitigation; in the case of COVID-19, technology improvements or supporting measures are required to reduce social and economic costs to acceptable levels. Infectious disease outbreaks can have devastating health and economic consequences. Effective public health strategies are 33 crucial for limiting transmission and minimizing these harms. One approach to controlling viral spread during pandemics -34 a "Find, Test, Trace, Isolate" (FTTI) strategy -relies on identifying and quarantining infectious individuals 1 . However, the 35 COVID-19 pandemic has demonstrated that FTTI systems reliant on lab-based tests are often limited by missed hidden 36 infection chains, which result from presymptomatic and asymptomatic transmission, and slow test result turnaround 37 times 2,3 . Digital contact tracing and frequent use of rapid tests have the potential to fill these gaps, but both approaches have 38 faced implementation barriers: inadequate participation levels, concerns around privacy and feasibility, and limited test 39 availability [4] [5] [6] . 40 41 Wearable sensors have already been established as tools to detect deviations from users' physiological baselines 7 . Recent 42 findings suggest that wearable sensors may also be able to detect infections caused by respiratory pathogens, including SARS-43 CoV-2, before or absent symptoms [8] [9] [10] . Alavi et al, for example, developed an algorithm that analyzes patterns in smartwatch-44 captured overnight resting heart rate and provides real-time alerts of potential presymptomatic and asymptomatic SARS-45 CoV-2 infection 10 . If such algorithms were widely deployed, wearable sensors could be promising tools for outbreak 46 mitigation, enabling FTTI systems to more rapidly identify (and subsequently isolate) infectious individuals, particularly 47 those without symptoms. Wearable sensors would also offer the unique benefit of passive monitoring, which minimizes 48 required user engagement, and could operate in privacy-preserving fashion because sensor data would not need to be shared 49 with a centralized database. With these potential benefits in mind, several studies have focused on developing wearable 50 sensor-based infectious disease detection algorithms; however, to the best of our knowledge, the real-world impact of 51 deploying these devices for pandemic mitigation has yet to be explored. 52 53 In this study, we assessed how wearable sensors can help reduce the burden of infection during a pandemic with the 54 overarching goal of guiding future research investment and policy. To do so, we used COVID-19 as an example and explored 55 counterfactual scenarios in which these devices were deployed to combat Canada's second wave. We built a compartmental 56 epidemiological model in which wearable devices notify users of potential infection and prompt users to seek a confirmatory 57 lab-based test, self-isolating while waiting for the result. We aimed to (1) assess the baseline impact of deploying currently 58 available detection algorithms, (2) investigate how detection accuracy and behavioural parameters influence this impact, and 59 (3) explore a complementary strategy in which rapid antigen tests are used to confirm wearable-informed notifications of 60 potential infection. 61 62 Counterfactual Scenarios 65 We simulated Canada's second COVID-19 wave (September 1, 2020 to February 20, 2021) . This time window allowed us 66 to capture the dynamics of wearable sensor deployment during an acute phase of the pandemic, prior to broad vaccine 67 availability, and at a time when the technology would have been ready and deployable. 68 69 First, we considered a baseline scenario in which wearable device users can download an application with currently available 70 detection algorithms 10 . Then, we investigated the impact of technology and behavioural parameters: detection sensitivity and 71 specificity; uptake, defined as the proportion of the population that has downloaded the application and uses their wearable 72 device often enough; and adherence, defined as the proportion of users who comply with recommended next steps after a 73 positive notification. Finally, we explored a complementary intervention where wearable device users with a positive 74 notification are offered a confirmatory rapid antigen test before they are prompted to seek a lab-based test and self-isolate. 75 76 Model description 77 We built a compartmental model based on a Susceptible, Exposed, Infectious, Removed (SEIR) framework ( Figure 1 ). We split 78 the Infectious state into three sub-states: Presymptomatic, Asymptomatic, and Symptomatic. All infected individuals enter the 79 Presymptomatic infectious state after a latency period following exposure; some go on to develop symptoms (Symptomatic) 80 while others do not (Asymptomatic). To incorporate wearable sensor deployment, we stratified Susceptible, Exposed We assumed perfect lab-based test accuracy and did not account for potential reinfections, which were likely negligible 97 during the simulation period 12 . We did not include a pathway for Symptomatic device users to enter Quarantined states 98 because it is likely that a large fraction of these individuals already underwent some degree of self-isolation -behaviour 99 accounted for in the historical transmission rate (β). In some scenarios, we also included a step where compliant users take a 100 confirmatory rapid antigen test: if positive, we assumed they then take a lab-based test, self-isolating while awaiting the result; 101 if negative, we assumed they return to normal behaviour. We investigated the impact of antigen test sensitivity in 102 Supplementary Appendix Section 5. 103 104 Simulation approach 105 To perform simulations, we first extracted the historical transmission rate (β) from the Institute for Health Metrics and 106 Evaluation (IHME) infection model, a time series "nowcasting" model for incidence of infection in Canada (π) 13 . The IHME 107 model estimates π by analyzing trends in confirmed cases, hospitalizations, and deaths; it validates the inferred π using 108 seroprevalence data. We downloaded these data from the IHME website on December 7, 2021. We used modelled values for 109 the incidence of infection because confirmed case counts are subject to incomplete case ascertainment and thereby 110 underestimate the extent of infection 14 . We calculated β from π using Equation (1); this time series for the historical 111 transmission rate incorporates all policy (e.g., restrictions, business closures, testing availability) and behavioural (e.g., 112 adherence to restrictions, quarantines) measures that occurred. N represents the size of the entire population and λ represents 113 the transmission potential in infected individuals without symptoms relative to those with symptoms. 114 115 116 117 We then applied β according to Equation (2) to simulate counterfactual scenarios. Because some Susceptible, Exposed, and 118 Infectious device users undergo self-isolation in the simulations, overall transmission decreases even though the transmission 119 rate for all others remains unchanged. In Supplementary Appendix Section 5, we investigated the possibility that users not 120 notified of potential infection act in a riskier fashion relative to historical behaviour 15 . a is a coefficient used to study this 121 possibility and is nominally set to 1. Other model parameters, equations, and assumptions are presented in Supplementary 122 Appendix Section 1. 123 124 We modeled asymptomatic prevalence (ρ), detection algorithm sensitivity (σw) and specificity (νw), and adherence (ψ) as beta-125 distributed random variables because these parameters were important sources of variance in our assessment of wearable 126 sensors as pandemic mitigation tools. We sampled these variables and used the resulting values to generate an epidemic 127 trajectory. We repeated this process 1,000 times, using these Monte Carlo simulations to model uncertainty in our estimates. 128 129 Outcome measures 130 We calculated the number of averted infections and the percent reduction in the burden of infection to quantify the health 131 impact of wearable sensor deployment. We measured the number of days incorrectly spent in quarantine per month per 132 device user (a consequence of false positive notifications) as the primary indicator of the strategy's social burden. To assess 133 resource consumption, we quantified the number of additional lab-based tests (and rapid antigen tests, where applicable) 134 required each day, on average. Finally, to provide more complete intuition around offering rapid antigen tests as a 135 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Baseline impact of wearable sensor deployment 146 We first investigated the baseline scenario in which detection algorithms that currently exist are made publicly available for 147 device users to download and use ( Figure 2 ) 10 . Upon notification of potential presymptomatic or asymptomatic infection, 148 users are prompted to seek a confirmatory lab-based test, self-isolate while awaiting the result (nominally, for 2 days), and 149 quarantine until recovery if positive. We used the nominal parameters in Supplementary Table 2, setting uptake, adherence, 150 detection sensitivity, and detection specificity to 4%, 50%, 80%, and 92%, respectively. 151 152 153 and detection specificity are set to 4%, 50%, 80%, and 92%, respectively. With 4% uptake, 219,700 (95% CI: 198,700-241,600) infections could have been averted during Canada's second COVID-158 19 wave -a 9.4% (95% CI: 8.5-10.3%) reduction in the burden of infection. However, the social costs were high: between 159 ~75,000 and ~125,000 device users were incorrectly self-isolating on any given day ( Figure 2b ). Moreover, between ~40,000 160 and ~65,000 additional lab-based tests were required each day (Figure 2c ), corresponding to a 51.8% (95% CI: 41.0-64.0%) 161 increase in demand relative to historical volumes. Historically, ~101,000 lab-based tests were performed each day, on average, 162 during the simulation time frame 13,17 . The number of individuals incorrectly in quarantine and daily demand for lab-based 163 tests were steady over time because they depend on the number of Susceptible device users, adherence, and detection 164 specificity; the gradual decrease can be attributed to the flow of users into the Removed state. 165 166 Tradeoff between detection algorithm sensitivity and specificity 167 After their initial release on technology platforms, health detection algorithms can be updated and improved as more real-168 world data are collected. However, it is often challenging to dramatically raise detection sensitivity and specificity at the same 169 time. We explored the implications of this tradeoff (Figure 3 ), varying detection sensitivity and specificity while keeping 170 uptake and adherence constant at 4% and 50%, respectively. 171 172 Increasing detection sensitivity increased the number of averted infections by prompting more Infectious users to self-isolate 173 (Figures 3a and 3b ). On the other hand, increasing specificity had a two-part effect. First, as specificity approached 100%, the 174 number of days incorrectly spent self-isolating approached zero ( Figure 3c ); sensitivity had negligible impact on incorrect 175 quarantines. Second, by virtue of decreasing the number of incorrect quarantines, increasing specificity resulted in a larger 176 pool of Susceptible individuals; in turn, fewer infections were averted. However, despite this second effect, incorrect 177 quarantines were not central to the strategy's public health impact. In the baseline scenario presented above (80% detection 178 sensitivity, 4% uptake, and 50% adherence), a 6.7% (5.9-7.3%) reduction in the burden of infection was still achievable with 179 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Impact of increasing uptake 192 Ensuring that public health measures reach sufficient levels of uptake has been a continued challenge through the COVID-193 19 pandemic. Digital contact tracing and vaccination efforts have demonstrated that well-constructed policies -for example, 194 incentivizing participation -can improve uptake of measures 18, 19 . Here, we explored the role of uptake to provide relevant 195 context for the design of wearable sensor deployment policies ( Figure 4 ; Supplementary Figure 1 ). We estimated that uptake 196 would fall between 0.5% and 7.5% (Supplementary Tables 2-4 ) at baseline but chose to present outcomes at all levels of 197 uptake to illustrate emergent phenomena. We also explored multiple technology scenarios, setting "high" detection 198 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 8, 2022. ; https://doi.org/10.1101/2022.02.07.22270634 doi: medRxiv preprint sensitivity and specificity at 96.0% and 98.4%, respectively; we based these increases on the respective goals of capturing 20% 199 more infections and reducing the false positive rate by 80% relative to nominal values. We kept adherence constant at 50%. 200 201 In all technology scenarios, increasing uptake averted more infections, though with diminishing returns (Figures 4a and 4b ). 202 As expected, improving detection specificity resulted in fewer averted infections when uptake is held constant; this effect was 203 most pronounced at ~30% to ~60% uptake. The number of days incorrectly spent in quarantine per month per device user 204 remained constant as a function of uptake but decreased from ~2.15 to ~0.45 when detection specificity was increased 205 (Figure 4c ). This ~80% decrease was consistent with our definition of "high specificity" demonstrating that detection 206 specificity directly influences the burden of incorrect quarantines on device users. The average daily demand for lab-based 207 tests scaled linearly with uptake, but at a slower rate with improved detection specificity ( Figure 4d ). 208 209 and High Specificity scenarios, detection specificity and sensitivity are kept at their nominal values, respectively. In (C) and (D), the 214 "Nominal Sensitivity and Specificity" and "High Sensitivity" curves overlap, and the "High Specificity" and "High Sensitivity and 215 Specificity" curves overlap. Impact of increasing adherence 218 Adherence to public health guidelines also impacts the success of pandemic control measures. Targeted policies -for 219 example, compensating individuals in self-isolation -could help improve compliance with public health recommendations 20 . 220 Here, we explored the role of adherence in wearable sensor deployment strategies ( is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 8, 2022. ; https://doi.org/10.1101/2022.02.07.22270634 doi: medRxiv preprint chose to present outcomes at all levels of adherence because compliance with public health guidelines could vary greatly, for 222 example, from as low as 14% to as high as 86% (Supplementary Table 2 ). We kept uptake constant at 4% and assessed multiple 223 technology scenarios using the same definitions of "high" detection sensitivity and specificity as above. 224 225 Adherence meaningfully impacted the burden of infection (Figure 5b ). For example, with nominal detection sensitivity and 226 specificity, increasing adherence among participating wearable device users from 20% to 80% tripled the achieved reduction 227 in the burden of infection, raising it from 4.2% (95% CI: 3.6-4.7%) to 13.6% (95% CI the "Nominal Sensitivity and Specificity" and "High Sensitivity" curves overlap, and the "High Specificity" and "High Sensitivity and 238 Specificity" curves overlap. Impact of offering confirmatory rapid antigen tests 241 Our earlier findings suggested that false positive notifications of potential infection were the primary cause of unnecessary 242 quarantines and lab-based tests. Improving detection specificity was one way to decrease false positive notifications. Here, 243 we investigated whether offering confirmatory rapid antigen tests to users with a positive notification could also contribute 244 to reducing unnecessary quarantines and lab-based tests ( Figure 6 ; Table 2; Supplementary Table 6 ). We considered multiple 245 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 8, 2022. scenarios, each with either low levels of uptake (0.5%) or adherence (14%), nominal levels of uptake (4%) or adherence (50%), 246 or high levels of uptake (12.5%) or adherence (86%). We examined these scenarios in the cases of nominal detection sensitivity 247 and specificity, and of "high" detection sensitivity and specificity (using the same definitions of "high" as above). 248 249 250 The use of antigen tests reduced the number of days incorrectly spent in quarantine by ~300-fold by increasing the "effective 258 specificity" of the strategy (Figure 6b ). That is, with antigen tests, the likelihood of a Susceptible user being incorrectly 259 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 8, 2022. ; https://doi.org/10.1101/2022.02.07.22270634 doi: medRxiv preprint prompted to quarantine on a given day fell from (1 -νw) to the product of (1 -νw) and (1 -νa), where νw and νa are detection 260 algorithm specificity and antigen test specificity, respectively. In earlier scenarios (Figures 4a and 5a) , averted infections were 261 decreased by improving detection specificity more than they were increased by improving detection sensitivity; fewer 262 infections were averted in the high detection sensitivity and specificity scenarios than in the nominal detection sensitivity 263 and specificity scenarios. Here, the specificity contributed by the antigen tests diminished the relative impact of improving 264 detection specificity on averted infections: the "effective specificity" of the strategy was 99.976% with nominal detection 265 specificity and 99.995% with high detection specificity (Supplementary Table 2 was what increased the number of averted infections. Importantly, antigen tests had the secondary effect of decreasing the 267 strategy's "effective sensitivity" -the product of antigen test sensitivity (91.1%) and detection algorithm sensitivity 21 . 268 269 Offering confirmatory rapid antigen tests also decreased the demand for lab-based tests by ~200-fold, providing the double 270 benefit of alleviating the burden on testing infrastructure and decreasing costs (Figure 6c ). We earlier found that in a baseline 271 scenario (4% uptake, 50% adherence, 80% detection sensitivity, 92% detection specificity), between ~40,000 and ~65,000 272 additional lab-based tests would be required each day (Figure 2c) infection chains with minimal delay and without active user engagement or broad sharing of user data. We showed that (1) 287 deploying today's detection algorithms could have meaningfully reduced the second wave burden of infection, but with 288 substantial social and resource costs; (2) improving detection algorithm specificity and offering confirmatory rapid antigen 289 tests can help minimize unnecessary quarantines and lab-based tests; and (3) once false positive notifications are minimized, 290 increasing uptake and adherence become effective strategies to scale the number of averted infections. 291 292 In theory, wearable sensor deployment reduces the burden of infection by decreasing the pool of infectious individuals (a 293 function of detection algorithm sensitivity). Here, we found that detection specificity played an unexpectedly large role as 294 well, with false positive notifications of potential infection prompting unnecessary quarantines and thereby decreasing the 295 pool of susceptible individuals. Thus, although prioritizing uptake and adherence as part of a wearable sensor deployment 296 strategy could mitigate a substantial number of infections, the unsustainable growth of associated costs should also be 297 considered. In a baseline scenario, without improvements to detection specificity, every user would spend over two days a 298 month on average incorrectly quarantining, and ~40,000 to ~65,000 additional confirmatory lab-based tests would be 299 required each day. The social and economic harm caused by solely promoting uptake or adherence without improvements 300 to detection specificity would likely undermine public confidence in and compliance with a wearable-based pandemic 301 mitigation strategy 22 . Alavi et al found that many false positives were due to the detection algorithm identifying lifestyle-302 driven changes in resting heart rate (e.g., after intense exercise or alcohol consumption); accounting for these factors using 303 more advanced algorithms may be one way to target improved detection specificity 10 . 304 305 We found that the inclusion of confirmatory antigen testing was a valuable mechanism, beyond improving detection 306 specificity, to increase the "effective specificity" of the strategy and decrease the overall false positive rate. The inclusion of 307 antigen testing decreased days incorrectly spent in quarantine by ~300-fold and brought the additional demand on lab-based 308 testing infrastructure to justifiable levels. In general, antigen tests were more cost-effective and immediate tools than lab-309 based tests to confirm a Susceptible device user was not infectious. However, even with the inclusion of antigen tests, 310 improvements to detection specificity still had value. Relative to scenarios with nominal detection specificity, with "high" 311 detection specificity, we observed a ~4-fold reduction in days incorrectly spent in quarantine per month per user, a ~2-fold 312 reduction in lab-based tests performed each day, and a ~5-fold reduction in antigen tests used each day. Importantly, a 313 strategy in which antigen tests support the deployment of wearable sensors is notably different from one involving frequent 314 use of rapid antigen tests for surveillance testing 23 . On their own, broad antigen test-based screening approaches require 315 tremendous manufacturing volumes, infrastructure, and funding 24 . Conversely, wearable sensors can non-invasively detect 316 infections without active user engagement, reducing the effort required to participate. Further, in the scenarios explored 317 here, detection algorithm specificity governed how efficiently rapid antigen tests were deployed. 318 319 Our work has important limitations. First, we assumed that SARS-CoV-2 epidemiology and wearable device use were 320 homogenous within the population. Our determination of the transmission rate from epidemiological data inherently results 321 in a "well-mixed" approximation for this value averaged over population-level heterogeneities such as age and super-322 spreading. As well, the COVID-19 pandemic has disproportionately impacted low-income and minority groups, while 323 younger and wealthier individuals are more likely to own wearable devices 25, 26 . Future studies could consider a policy where 324 the incentive to download the application is increased to become a subsidy for purchasing a wearable device, reducing the 325 participation barrier. Second, we used an existing model for the incidence of infection which has its own assumptions and 326 limitations 13 . Third, we made the simplifying assumption that all users without symptoms (and that no users with symptoms) 327 could benefit from wearable-informed prompts to take a confirmatory test and self-isolate. Fourth, we did not consider how 328 uptake or adherence might vary over time or with detection accuracy 18, 22 . Fifth, we used median values for SARS-CoV-2 329 infection parameters (e.g., latent period) and did not account for reinfections or vaccinations. Finally, we did not account 330 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 8, 2022. ; https://doi.org/10.1101/2022.02.07.22270634 doi: medRxiv preprint for administrative costs or second order savings (e.g., avoided worker's compensation payouts for 14-day quarantines). 331 332 To our knowledge, this is the first study to explore the real-world impact of deploying wearable sensors for pandemic 333 mitigation. Using the example of COVID-19, we demonstrated that these devices have the potential to support FTTI systems 334 with real-time detection of presymptomatic and asymptomatic infections, and ultimately reduce the burden of infection. 335 However, in cases with insufficient detection algorithm specificity, complementary interventions that reduce false positives 336 are required to minimize social costs and resource demands. In the future, there is clear merit to further exploring how 337 wearable sensors can be incorporated into FTTI systems for pandemic mitigation, and whether these devices continue to 338 have public health utility once an endemic phase is reached, complementary to vaccines. 339 340 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 8, 2022 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 8, 2022. ; https://doi.org/10.1101/2022.02.07.22270634 doi: medRxiv preprint 409 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 8, 2022. ; https://doi.org/10.1101/2022.02.07.22270634 doi: medRxiv preprint Supplementary Table 1 : SARS-CoV-2 characteristics. We obtained the presymptomatic infectious period by subtracting the latent period (3.69 days) from the incubation period (5 days) 1,2 . We obtained the asymptomatic and symptomatic infectious period by subtracting the presymptomatic infectious period (1.31 days) from the total infectious period (7 days) 1-3 . During Monte Carlo simulations, we modeled asymptomatic prevalence as a beta random variable with a mean of 0.4 and a sample size of 200; a sample size of 200 is greater than 75% of the study populations examined by Oran and colleagues 4 . We defined uptake as the percent of the population that owns a wearable device, has downloaded the detection/notification application, and uses the device enough to collect sufficient data for detection. We estimated uptake would range from 0.5% to 7.5% at baseline. Supplementary Tables 3 and 4 provide an example of this calculation. Device ownership: Estimates from 2018 place device ownership in Canada between 22% and 25% 5,6 . Download rate: A study found that the baseline download rate of Germany's national contact tracing application was between ~8% and ~11%; incentives could increase this rate 7 . Paré and colleagues found that 57% of owners regularly track their health with their device 5 . Here, we looked at download rates ranging from 10% to 60%. Utilization: In research studies where wearable devices were used to track health, usage rates ranged from as low as 24%, to 50% in the long run 8, 9 . Adherence to wearable device notification ψ 50% We defined adherence as the proportion of wearable device users that comply with recommended next steps upon notification of potential infection. At baseline, next steps include seeking a confirmatory lab-based test, self-isolating while awaiting a result, and quarantining until recovery if the result is positive. With antigen tests, compliant users also take a confirmatory rapid antigen test prior to seeking a lab-based test. In Israel, at least ~53% of antigen test kit results were reported (~613,000 reports out of ~1,150,000 kits taken home) 10, 11 . In Norway, up to 70% of those with a suspected diagnosis and up to 86% with a positive diagnostic test adhered to quarantine 12 . However, adherence could be as low as ~14%, if one considers Canada's COVID Alert contact tracing app's reporting rate in light of confirmed cases as of July 27, 2021 13 . During Monte Carlo simulations, we modeled adherence as a beta random variable with a mean of 0.5 and a sample size of 1723; 1723 was the sample size for the relevant experiment in the Norway study. Detection algorithm sensitivity σw 80% We defined sensitivity as the proportion of infected yet asymptomatic wearable device users (i.e., Exposed, Presymptomatic, and Asymptomatic) who receive a notification of potential infection prior to recovering and entering the Removed compartment. Alavi and colleagues' NightSignal algorithm achieved a sensitivity of ~80%, which is a plausible value based on other efforts to develop similar algorithms 14, 15 . During Monte Carlo simulations, we modeled sensitivity as a beta random variable with a mean of 0.80 and a sample size of 84; 84 was the size of the sample used to calculate the NightSignal algorithm's sensitivity. Detection algorithm specificity νw 92% We defined specificity as the probability that, on a given day, a healthy (i.e., Susceptible) user does not receive a notification of potential infection. Alavi and colleagues' NightSignal algorithm gave potentially healthy users 0.0819 false positive notifications ("red alerts") per day on average, corresponding to a specificity of ~92% 14 . During Monte Carlo simulations, we modeled specificity as a beta random variable with a mean of 0.92 and a sample size of 818; alarm data from 818 potentially healthy users in Alavi and colleagues' dataset were used to calculate the false positive rate. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) We assumed that σw is applied uniformly across Exposed, Presymptomatic, and Asymptomatic states such that by the time infectiousness ends, σw of infected users without symptoms are notified. Detection algorithm specificity adjustment factor We assumed that νw is applied over a period of one day such that on any given day, Susceptible users receive an incorrect (i.e., false positive) notification of potential infection with probability (1-νw). Rapid antigen test sensitivity σa 91.1% We used the lowest performance reported for Abbot's Panbio test 16 . Independent evaluations of this test suggest lower sensitivity in presymptomatic and asymptomatic individuals 17, 18 . However, we reasoned that the receipt of a wearable-informed notification of potential infection raised the pretest probability of infection, thereby improving the negative predictive value (NPV) of the tests 19 . We performed a sensitivity analysis on the sensitivity of rapid antigen tests (Supplementary Figure 5) Model equations, in addition to Equation (1), used to extract transmission rate (β) from the IHME infection model: Model equations, in addition to Equation (2), used to run simulations: . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 8, 2022. ; https://doi.org/10.1101/2022.02.07.22270634 doi: medRxiv preprint . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 8, 2022. ; https://doi.org/10.1101/2022.02.07.22270634 doi: medRxiv preprint Below, Supplementary Tables 3 and 4 delineate how we estimated plausible ranges for uptake in a baseline scenario. First, we multiplied the download rate by the proportion of the population that owns a device to obtain a plausible range for the proportion of the population that owns the application (Supplementary Table 3 ). Then, we calculated a range for uptake by multiplying the proportion of individuals that own the application by expected levels of utilization (Supplementary Table 4 ). Accounting for utilization was a necessary step because not all individuals who download the application to their device use it enough to provide sufficient data for the algorithm to function correctly 14 . We concluded that in a baseline scenario, uptake would likely range from 0.5% to 7.5%. Assumptions around parameter values are listed in Supplementary Table 2 above. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 8, 2022. ; https://doi.org/10.1101/2022.02.07.22270634 doi: medRxiv preprint To generate a first-order estimate of net healthcare expenditures in particular scenarios, we subtracted savings from expenditures. Savings included costs avoided from averting hospitalizations. Expenditures included the costs of labbased tests and antigen tests, where applicable. We calculated the number of averted hospitalizations and tests from our simulations using Equations (22) to (24) below. We multiplied these volumes by the costs in Supplementary Table 5 , as in Equation (25), to generate a first-order approximation of net healthcare expenditures. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 8, 2022. ; https://doi.org/10.1101/2022.02.07.22270634 doi: medRxiv preprint Supplementary Figure 1 : Impact of simultaneously increasing uptake and adherence. Averted infections (A), reduction in the burden of infection (B), days incorrectly spent in quarantine per month per device user (C), and average daily demand for lab-based tests (D), all over the entire simulation period, as a function of uptake and adherence. Grey boxes denote nominal sensitivity (80%) and specificity (92%). . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 8, 2022. ; https://doi.org/10.1101/2022.02.07.22270634 doi: medRxiv preprint First, we looked at whether, instead of remaining constant, the transmission rate of device users who do not receive a notification of potential infection might in fact increase due to a sense of false confidence (Supplementary Figure 2) 21 . We modulated a in Equation (2) to do so; a 5% increase in the transmission rate, for example, meant a was set to 1.05. Increase in transmission among device users relative to historical levels reduced the number of averted infections. The number of incorrect quarantines was not impacted. The implication of this finding is that public health leaders would need to communicate the limitations of wearable sensors with respect to detecting infections and emphasize that a lack of a notification does not rule out potential infection. Figure 2 : Impact of increased transmission among device users who are not notified of potential infection in a baseline scenario. We assumed 4% uptake, 50% adherence, and that transmission among non-users was unchanged. Second, we looked at the impact of asymptomatic prevalence (Supplementary Figure 3) . It was important to perform this analysis because our model only accounts for notifications sent to presymptomatic and asymptomatic individuals, yet there is still a lack of consensus on a specific value for the asymptomatic prevalence 4 . As expected, with greater asymptomatic prevalence, more individuals could benefit from wearable device use and more infections could be averted. The success of this strategy was not dependent on a particular value of asymptomatic prevalence. The number of incorrect quarantines was not impacted. Figure 3 : Impact of asymptomatic prevalence in a baseline scenario. We assumed 4% uptake and 50% adherence. We continued to model asymptomatic prevalence as a beta-distributed random variable (Supplementary Table 1 ). The dashed grey line represents nominal asymptomatic prevalence (40%). . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted February 8, 2022. ; https://doi.org/10.1101/2022.02.07.22270634 doi: medRxiv preprint Third, we investigated how the decrease in the number of Susceptible individuals resulting from incorrect quarantines influenced the number of averted infections in a baseline scenario (Supplementary Figure 4) . We compared the number of averted infections with nominal (92%) and perfect (100%) detection specificity as detection sensitivity increased. In a baseline scenario, a meaningful proportion -28.6% (95% CI: 18.3-38.2%) in the case of nominal detection sensitivity -of averted infections were driven by incorrect quarantines. This proportion decreased with increasing sensitivity. Consistent with earlier findings, it remains important to minimize unnecessary quarantines -social costs can be substantially reduced while still averting a meaningful number of infections, especially if detection sensitivity can be improved in parallel. Figure 4 : Impact of incorrect quarantines on averted infections in a baseline scenario. We assumed 4% uptake and 50% adherence. The dashed grey line depicts nominal detection algorithm sensitivity (80%). Fourth, we investigated the impact of lower rapid antigen test sensitivity (Supplementary Figure 5) . First, fewer infections were averted overall -as discussed, using antigen tests to minimize incorrect quarantines increased the pool of susceptible individuals. Second, averted infections grew linearly with test sensitivity: a ~10% increase in test sensitivity resulted in a ~14,000 increase in averted infections. These two effects result in a tradeoff between missing more infectious individuals (imperfect antigen test sensitivity) and decreasing false positive prompts to seek a labbased test and self-isolate while awaiting the results (near perfect antigen test specificity). We believe the use of antigen tests as a complementary mechanism could be justified. Although fewer infections are averted relative to wearable sensor deployment without antigen tests, hundreds of thousands of infections are still averted relative to the counterfactual scenario -and in a resource-efficient and socially acceptable fashion. Certainly, infected individuals with a false negative antigen test might act in a riskier fashion -even still, there remains an opportunity to avert a substantial number of infections (Supplementary Figure 2) . We also point out that improving detecting algorithm sensitivity could help counteract the effect of imperfect antigen test sensitivity (Table 2) . Figure 5 : Impact of antigen test sensitivity. We assumed 4% uptake and 50% adherence. The dashed grey line represents nominal antigen test sensitivity (91.7%). . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted February 8, 2022. ; https://doi.org/10.1101/2022.02.07.22270634 doi: medRxiv preprint Fifth, we explored the impact of lab-based test turnaround time to determine whether minimizing this variable should be a policy priority (Supplementary Figure 6) . Throughout this study, we set turnaround time to its nominal value of two days. With longer turnaround times, individuals incorrectly in quarantine would remain there longer, further decreasing the pool of Susceptible individuals. As expected, more infections are consequently averted. However, there are other mechanisms (e.g., improving detection sensitivity) for increasing averted infections that are not accompanied by as large of an increase to social costs. Thus, as is already the case outside the context of wearable sensor deployment, it would make sense to minimize turnaround time. Figure 6 : Impact of lab-based test turnaround time. We assumed 4% uptake and 50% adherence. Finally, to understand the impact of detection algorithm sensitivity on the incidence of infection, we investigated the scenario in which device users are randomly asked to seek a lab-based test and self-isolate while awaiting the result (Supplementary Figure 7) . We set the likelihood of being asked to quarantine to the false positive rate, still treating detection specificity as a beta-distributed random variable and setting it to its nominal value. As expected, the reduction in detection sensitivity substantially reduces the number of averted infections. The number of individuals incorrectly in quarantine is unimpacted because it is governed by detection specificity, not sensitivity. Figure 7 : Impact of randomly asking device users to seek a lab-based test and quarantine while waiting for the result. We assumed 7.5% uptake, still with 50% adherence, to illustrate the relative difference in the incidence of infection. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted February 8, 2022. ; https://doi.org/10.1101/2022.02.07.22270634 doi: medRxiv preprint What do countries need to do to implement effective 'find, test, trace High Detection Sensitivity (96.0%) and Specificity Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2) The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application Viral dynamics in asymptomatic patients with COVID-19 Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review Diffusion of the Digital Health Self-Tracking Movement in Canada: Results of a National Survey Activity fitness tracker household penetration rate in Canada Tracking and promoting the usage of a COVID-19 contact tracing app Feasibility of large-scale deployment of multiple wearable sensors in Parkinson's disease Harnessing wearable device data to improve statelevel real-time surveillance of influenza-like illness in the USA: a population-based study Returning to school, again: 'Operation Antigen 2' is underway, and only negatives will be admitted to institutions 613,000 reported, about 550 positive: Antigen results -and those that will arrive tomorrow without testing Public adherence to governmental recommendations regarding quarantine and testing for COVID-19 Government of Canada. How many people are using COVID Alert International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted Real-time alerting system for COVID-19 and other stress events using wearable data Passive detection of COVID-19 with wearable sensors and explainable machine learning algorithms In vitro diagnostic rapid test for qualitative detection of SARS-CoV-2 antigen (Ag) Evaluation of a rapid antigen test (Panbio TM COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients Screening for SARS-CoV-2 infection in asymptomatic individuals using the Panbio COVID-19 antigen rapid test (Abbott) compared with RT-PCR: a prospective cohort study False Negative Tests for SARS-CoV-2 Infection -Challenges and Implications Testing for COVID-19: How and where we test for active infections A Caveat to Using Wearable Sensor Data for COVID-19 Detection: The Role of Behavioral Change after Receipt of Test Results Canadian Institute for Health Information. COVID-19 Hospitalization and Emergency Department Statistics Institute for Health Metrics and Evaluation (IHME) COVID-19 Projections World Health Organization. Global partnership to make available 120 million affordable, quality COVID-19 rapid tests for low-and middle-income countries Most Coronavirus Tests Cost About $100. Why Did One Cost $2,315?